| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-06 |
| mRNA |
TG-101348 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
| mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
6e-05 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
8e-05 |
| mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
Sorafenib |
CCLE |
pan-cancer |
AAC |
0.18 |
0.0001 |